Skip to main content

Published locations for Dupilumab hits the mark for severe AD in younger children

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Dupilumab hits the mark for severe AD in younger children

User login

  • Reset your password
  • /content/dupilumab-hits-mark-severe-ad-younger-children
  • /clinicianreviews/article/220479/atopic-dermatitis/dupilumab-hits-mark-severe-ad-younger-children
  • /edermatologynews/article/220479/atopic-dermatitis/dupilumab-hits-mark-severe-ad-younger-children
  • /familypracticenews/article/220479/atopic-dermatitis/dupilumab-hits-mark-severe-ad-younger-children
  • /pediatricnews/article/220479/atopic-dermatitis/dupilumab-hits-mark-severe-ad-younger-children
  • /pediatrics/article/220479/atopic-dermatitis/dupilumab-hits-mark-severe-ad-younger-children
  • /dermatology/article/220479/atopic-dermatitis/dupilumab-hits-mark-severe-ad-younger-children
  • /familymedicine/article/220479/atopic-dermatitis/dupilumab-hits-mark-severe-ad-younger-children